Albert Pérez-Ladaga

653 citations
4 papers · 494 indexed · 1 hit paper · h-index 3
Topics
Acute Myeloid Leukemia Research (2 papers)Acute Kidney Injury Research (2 papers)Cancer Genomics and Diagnostics (1 paper)

In The Last Decade

Albert Pérez-Ladaga

4 papers receiving 491 citations

Hit Papers

TET2 mutations predict response to hypomethylating agents...20142026201820222014100200300400

Peers

Albert Pérez-Ladaga
Comparison fields: 5 of 57
  • Hematology 362
  • Molecular Biology 214
  • Genetics 148
  • Immunology 58
  • Cancer Research 58
Replace Tetsuichi Yoshizato with:
Tetsuichi Yoshizato Japan
Ali Amin Asnafi Iran
Kaveh Jaseb Iran
Carlos Hader United States
Anna Colpo Italy
Cuihong Wei Canada
Irini Xilouri Greece
Tiejun Qin China
M Hasib Sidiqi United States
Stephen R. Zeldenrust United States
Albert Pérez-Ladaga relative to Tetsuichi Yoshizato Japan Tetsuichi Yoshizato's profile →
Citations per field
00.5×3.3×
Tetsuichi Yoshizato · 1×
Citations per year

Countries citing papers authored by Albert Pérez-Ladaga

Since Specialization
Citations

This map shows the geographic impact of Albert Pérez-Ladaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Pérez-Ladaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Pérez-Ladaga more than expected).

Fields of papers citing papers by Albert Pérez-Ladaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Pérez-Ladaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Pérez-Ladaga. The network helps show where Albert Pérez-Ladaga may publish in the future.

Co-authorship network of co-authors of Albert Pérez-Ladaga

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Pérez-Ladaga. A scholar is included among the top collaborators of Albert Pérez-Ladaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Pérez-Ladaga. Albert Pérez-Ladaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Albert Pérez-Ladaga

Albert Pérez-Ladaga is a scholar working on Nephrology, Hematology and Cancer Research, having authored 4 papers that have together received 494 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Acute Kidney Injury Research (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hematology (362 citations), Genetics (148 citations) and Nephrology (40 citations). Albert Pérez-Ladaga has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Petar Stojanov, David P. Steensma, Allegra M. Lord, Bennett Adam Caughey, Rui Chen, Donna Neuberg, Rafael Bejar, Kristen E. Stevenson, Gad Getz and Guillermo Garcia‐Manero. Their work appears in journals such as Blood, Kidney International and European Journal of Inflammation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026